MELT PHARMACEUTICALS Trademark

Trademark Overview

On Friday, September 30, 2022, a trademark application was filed for MELT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the MELT PHARMACEUTICALS trademark a serial number of 97614559. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, March 19, 2025. This trademark is owned by Melt Pharmaceuticals, Inc.. The MELT PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
melt pharmaceuticals

General Information

Serial Number97614559
Word MarkMELT PHARMACEUTICALS
Filing DateFriday, September 30, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, March 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMelt Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37205
Party NameMelt Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37205

Trademark Events

Event DateEvent Description
Tuesday, October 4, 2022NEW APPLICATION ENTERED
Tuesday, October 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, May 25, 2023ASSIGNED TO EXAMINER
Friday, May 26, 2023NON-FINAL ACTION WRITTEN
Friday, May 26, 2023NON-FINAL ACTION E-MAILED
Friday, May 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 12, 2024SOU EXTENSION 1 FILED
Monday, February 12, 2024SOU EXTENSION 1 GRANTED
Tuesday, February 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, September 11, 2024SOU EXTENSION 2 FILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, November 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 20, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, November 20, 2024SOU EXTENSION 2 GRANTED
Wednesday, November 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2024CORRECTED NOA E-MAILED
Monday, March 10, 2025SOU EXTENSION 3 FILED
Monday, March 10, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, March 19, 2025SOU EXTENSION 3 GRANTED
Wednesday, March 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

pharmaceuticals melt surgical procedure conscious sedation after during compositions administration prior pharmaceutical